Werner Zoellner

SEED Karlsruhe GmbH (SEED) is the venture capital operation of L-EigenkapitalAgentur (L-EA), part of the private equity arm and an affiliate of LBBW-Landesbank Baden-Württemberg. SEED has offices in Karlsruhe, Freiburg, Munich and Tübingen and invests venture capital with L-EA on behalf of the LBBW group. Their early investors also have included TBG-Technologie Beteiligungs GmbH which is part of the government-controlled KfW Bank group, as well as high net-worth private individuals.

Valtronic Technologies (Suisse) SA designs and manufactures implantable electronics and micromechanics for both medical and non-medical applications. Its solutions include innovation, development & industrialization, manufacturing, supply chain management, technologies and quality. The company was founded in 1982 and is headquartered in Les Charbonnieres, Switzerland.

Tinnitus Forschungs- und Entwicklungs GmbH engages in the research and development of pharmacological drugs. They specialize in the preparation of drugs and adamantane derivatives for the treatment of tinnitus and inner ear-related diseases. Their focus areas cover pharmacological research, clinical development, laboratory testing, and patent application. The company is headquartered in Wörthsee, Germany.

flyion GmbH is engaged in the development and sale of ion channel screening solutions. Its products include Flyscreen 8500, Patchbox, and ChipTip. The company was founded by Albrecht Lepple-Wienhues and Klaus Ferlinz in 2001 and is headquartered in Tubingen, Germany.

TNI medical AG develops, produces, and sells diagnostic and therapeutic devices for breathing therapy. Its products are primarily used for home treatments, especially during sleep. TNI medical focuses on maximizing patient comfort with simultaneous simplification of the application. The company was founded by Michael Lauk and Malaika Lauk in 2007 and is headquartered in Wuerzburg, Germany.

ProteoSys AG offers biotechnology research services. It provides solutions for the drug development process focusing on target system discovery, target validation, modes of action, studies of side effects and toxicology. The company was founded by André Schrattenholz and Helmut Matthies in 2000 and is headquartered in Mainz, Germany.

Baden-Württemberg Connected eV supports and promotes businesses. The company was founded in 1997 and is headquartered in Stuttgart, Germany.

Patrimonium Medical Technologies Advisors AG provides asset management and investment consulting services for the medical sector. The private company is based in Baar, CH. and has subsidiaries in United States and Switzerland. The Swiss company was founded in 2009 by Christoph D. Syz. Christoph D. Syz has been the CEO since 2009.